Enterocolitis, Pseudomembranous: Clinical Trials

7 trials for Enterocolitis, Pseudomembranous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 2 withdrawn, 1 completed, 1 not yet recruiting. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Terminated 2, Withdrawn 2, Completed 1, Not yet recruiting 1, Unknown 1

Follow Enterocolitis, Pseudomembranous: new trials by email Literature Review of Enterocolitis, Pseudomembranous trials Research Report on Enterocolitis, Pseudomembranous

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Effect of Antibiotics on Enteric Neurons and Glia
Amoxicillin Oral Capsule - Antibiotic Enterocolitis
Phase 4CompletedRockefeller University102023-06-232026-03-12
Bezlotoxumab Versus FMT for Multiple Recurrent CDI
Bezlotoxumab, Fecal Microbiota Transplantation (FMT), Vancomycin oral - Clostridium Infections, Clostridioides Difficile
Phase 4WithdrawnLeiden University Medical Center2022-01-012023-03-28
Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.
Bezlotoxumab, Normal Saline - Clostridia Difficile Colitis, Clostridium; Sepsis
Phase 4TerminatedOhio State University52019-08-192026-06-18
Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe
Nu-Lytely - Clostridium Difficile Colitis
Phase 4UnknownAscension Health2002012-06-012012-08-17
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Lactobacillus GG - Enterocolitis, Pseudomembranous Colitis
Phase 4WithdrawnMichael E. DeBakey VA Medical Center2008-08-012017-05-10
The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study
Synbiotic 2000 - Surgical Wound Infection, Cystitis
Phase 4TerminatedBeth Israel Medical Center402005-11-012007-11-01

Narrower conditions

Bacteremia (1)  ·  Calciphylaxis (1)  ·  Clostridium Infections (1)  ·  Colitis, Ulcerative (1)  ·  Craniocerebral Trauma (1)  ·  Crohn Disease (1)  ·  Cystitis (1)  ·  Enterocolitis (1)  ·  Epidermolysis Bullosa (1)  ·  Frostbite (1)  ·  Graft vs Host Disease (1)  ·  Hypospadias (1)  ·  Invasive Fungal Infections (1)  ·  Multiple Sclerosis (1)

Broader conditions

Bacterial Infections (7)  ·  Bacterial Infections and Mycoses (7)  ·  Digestive System Diseases (7)  ·  Gastroenteritis (7)  ·  Gastrointestinal Diseases (7)  ·  Gram-Positive Bacterial Infections (7)  ·  Infections (7)  ·  Intestinal Diseases (7)  ·  Clostridium Infections (6)  ·  Enterocolitis (6)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Inflammation (2)

Interventions

bezlotoxumab (2)  ·  Amoxicillin (1)  ·  Fecal Microbiota Transplantation (1)  ·  Lacteol (1)  ·  Oxygen (1)  ·  Saline Solution (1)  ·  Vancomycin (1)  ·  polyethylene glycol 3350 (1)

Sponsors

Ascension Health (1)  ·  Beth Israel Medical Center (1)  ·  Jay C. Buckey Jr. (1)  ·  Leiden University Medical Center (1)  ·  Michael E. DeBakey VA Medical Center (1)  ·  Ohio State University (1)  ·  Rockefeller University (1)

Countries

United States (5)  ·  Netherlands (1)

Top investigators

Begum Aydin, PhD (1)  ·  Daniel M Musher, M.D. (1)  ·  David S Seres, MD (1)  ·  J van Prehn (1)  ·  Jay Buckey (1)  ·  Mark B. Vance, DO (1)  ·  Yelina Alvarez, MD/PhD (1)